New study tracks Darolutamide's Real-World impact on advanced prostate cancer
NCT ID NCT07344779
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study follows about 1,600 men with metastatic hormone-sensitive prostate cancer who are taking darolutamide plus hormone therapy, with or without chemotherapy. Researchers will track how many men have undetectable PSA levels after one year, as well as overall survival and side effects. The goal is to see how well this treatment works in everyday medical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many Locations
Multiple Locations, Belgium
-
Many Locations
Multiple Locations, Finland
-
Many Locations
Multiple Locations, France
-
Many Locations
Multiple Locations, Germany
-
Many Locations
Multiple Locations, Greece
-
Many Locations
Multiple Locations, Israel
-
Many Locations
Multiple Locations, Italy
-
Many Locations
Multiple Locations, Lithuania
-
Many Locations
Multiple Locations, Norway
-
Many Locations
Multiple Locations, Poland
-
Many Locations
Multiple Locations, Portugal
-
Many Locations
Multiple Locations, Saudi Arabia
-
Many Locations
Multiple Locations, Spain
-
Many Locations
Multiple Locations, Sweden
-
Many Locations
Multiple Locations, Switzerland
-
Many Locations
Multiple Locations, United Kingdom